Hyeon Woong Kang
4PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Dec 24, 2025
SLC6A14-mediated glutamine promotes SYTL4-CXCL8 axis activation to drive gemcitabine resistance and immune evasion in pancreatic cancer.Hyeon Woong Kang, Ju Hyun Kim, Jae Woong Jeong
|Mar 07, 2025
SLC5A3 depletion promotes apoptosis by inducing mitochondrial dysfunction and mitophagy in gemcitabine-resistant pancreatic cancer cells.Minsoo Kim, Woosol Chris Hong, Hyeon Woong Kang
|Nov 02, 2023
Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer.Hyeon Woong Kang, Ju Hyun Kim, Da Eun Lee
|Oct 27, 2023
SLC38A5 Modulates Ferroptosis to Overcome Gemcitabine Resistance in Pancreatic Cancer.Myeong Jin Kim, Hyung Sun Kim, Hyeon Woong Kang
Pageof 1
Frequent Collaborators
3 joint publications
Hyo Jung Kim
2 joint publications
Joon Seong Park
2 joint publications
SungSoon Fang
1 joint publications
Ju Hyun Kim
1 joint publications
Da Eun Lee
1 joint publications
Myeong Jin Kim
1 joint publications
Hyung Sun Kim
1 joint publications
Bo Eun Lee
1 joint publications
Kyung Jin Lee
1 joint publications
Jongman Yoo
